ZyVersa Therapeutics (ZVSA) Competitors $0.14 0.00 (-1.55%) As of 09/5/2025 03:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZVSA vs. JAGX, SHPH, CNSP, ENVB, GRI, BDRX, GTBP, QLGN, RDHL, and PRFXShould you be buying ZyVersa Therapeutics stock or one of its competitors? The main competitors of ZyVersa Therapeutics include Jaguar Animal Health (JAGX), Shuttle Pharmaceuticals (SHPH), CNS Pharmaceuticals (CNSP), Enveric Biosciences (ENVB), GRI Bio (GRI), Biodexa Pharmaceuticals (BDRX), GT Biopharma (GTBP), Qualigen Therapeutics (QLGN), Redhill Biopharma (RDHL), and PainReform (PRFX). These companies are all part of the "pharmaceutical products" industry. ZyVersa Therapeutics vs. Its Competitors Jaguar Animal Health Shuttle Pharmaceuticals CNS Pharmaceuticals Enveric Biosciences GRI Bio Biodexa Pharmaceuticals GT Biopharma Qualigen Therapeutics Redhill Biopharma PainReform ZyVersa Therapeutics (NASDAQ:ZVSA) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations. Which has better valuation and earnings, ZVSA or JAGX? ZyVersa Therapeutics has higher earnings, but lower revenue than Jaguar Animal Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZyVersa TherapeuticsN/AN/A-$9.41MN/AN/AJaguar Animal Health$11.69M0.33-$38.49MN/AN/A Is ZVSA or JAGX more profitable? ZyVersa Therapeutics has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -344.16%. ZyVersa Therapeutics' return on equity of -109.54% beat Jaguar Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets ZyVersa TherapeuticsN/A -109.54% -43.95% Jaguar Animal Health -344.16%-660.18%-77.42% Do institutionals and insiders hold more shares of ZVSA or JAGX? 3.9% of ZyVersa Therapeutics shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 0.2% of ZyVersa Therapeutics shares are held by company insiders. Comparatively, 4.6% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend ZVSA or JAGX? Jaguar Animal Health has a consensus target price of $60.00, suggesting a potential upside of 3,289.83%. Given Jaguar Animal Health's stronger consensus rating and higher probable upside, analysts plainly believe Jaguar Animal Health is more favorable than ZyVersa Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZyVersa Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Jaguar Animal Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor ZVSA or JAGX? In the previous week, ZyVersa Therapeutics had 3 more articles in the media than Jaguar Animal Health. MarketBeat recorded 4 mentions for ZyVersa Therapeutics and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.50 beat ZyVersa Therapeutics' score of 0.22 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Overall Sentiment ZyVersa Therapeutics Neutral Jaguar Animal Health Positive Which has more volatility & risk, ZVSA or JAGX? ZyVersa Therapeutics has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Jaguar Animal Health has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. SummaryJaguar Animal Health beats ZyVersa Therapeutics on 7 of the 13 factors compared between the two stocks. Get ZyVersa Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZVSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZVSA vs. The Competition Export to ExcelMetricZyVersa TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13M$3.17B$5.83B$9.92BDividend YieldN/A2.26%6.70%4.52%P/E RatioN/A21.1076.1526.11Price / SalesN/A471.55563.98189.73Price / CashN/A45.7236.9959.28Price / Book0.049.8711.486.09Net Income-$9.41M-$53.42M$3.29B$266.51M7 Day Performance21.57%2.93%1.27%0.45%1 Month Performance-17.81%11.43%8.56%5.05%1 Year Performance-94.43%16.14%61.18%26.03% ZyVersa Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZVSAZyVersa Therapeutics0.9483 of 5 stars$0.14-1.5%N/A-94.4%$1.13MN/A0.002Gap DownJAGXJaguar Animal Health2.4899 of 5 stars$1.67+2.5%$60.00+3,492.8%-93.6%$3.62M$11.69M0.0050Positive NewsShort Interest ↓Gap UpSHPHShuttle Pharmaceuticals0.765 of 5 stars$3.38+2.4%N/A-91.7%$3.62MN/A-0.815News CoverageCNSPCNS Pharmaceuticals1.6394 of 5 stars$6.26+1.0%$300.00+4,691.6%-92.8%$3.57MN/A0.005Analyst DowngradeENVBEnveric Biosciences2.3215 of 5 stars$1.09-3.5%$10.00+817.4%-88.0%$3.54MN/A-0.0320News CoveragePositive NewsGap DownGRIGRI Bio3.1974 of 5 stars$1.40+0.7%$22.00+1,471.4%-80.9%$3.52MN/A-0.121News CoverageShort Interest ↓Gap DownBDRXBiodexa Pharmaceuticals0.5696 of 5 stars$5.35-3.5%N/AN/A$3.31M$470K0.0020Positive NewsShort Interest ↓GTBPGT Biopharma2.1849 of 5 stars$0.90-3.8%$11.00+1,123.3%-51.8%$3.20MN/A-0.228News CoverageAnalyst UpgradeQLGNQualigen TherapeuticsN/A$1.79flatN/A-78.8%$3.04M$4.98M0.0050News CoverageShort Interest ↓RDHLRedhill BiopharmaN/A$1.30-3.7%N/A-84.7%$2.99M$8.04M0.00210News CoverageShort Interest ↓Gap UpPRFXPainReform0.8082 of 5 stars$1.38-4.8%N/A+38.0%$2.77MN/A-0.014Positive NewsGap Down Related Companies and Tools Related Companies JAGX Alternatives SHPH Alternatives CNSP Alternatives ENVB Alternatives GRI Alternatives BDRX Alternatives GTBP Alternatives QLGN Alternatives RDHL Alternatives PRFX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZVSA) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZVSA Stock Alerts